<?xml version="1.0" encoding="UTF-8"?>
<p>One study reported that approximately 85â€“100% of the adult population has antibodies against HMPV, and it is likely that these preexisting antibodies are not completely protective. Insufficient immunity acquired during initial infection and/or due to infections from different genotypes does not cause cross-protection immunity. All of this suggests that re-infection throughout life may be common [
 <xref rid="B20-pathogens-09-00085" ref-type="bibr">20</xref>,
 <xref rid="B21-pathogens-09-00085" ref-type="bibr">21</xref>,
 <xref rid="B22-pathogens-09-00085" ref-type="bibr">22</xref>]. Despite the fact that HMPV infection occurs mildly in healthy younger adults, infection with HMPV increases disease severity and high morbidity and mortality rates in the elderly [
 <xref rid="B11-pathogens-09-00085" ref-type="bibr">11</xref>].
</p>
